MODV News

Modivcare Receives Nasdaq Delisting Notice Following Chapter 11 Filing

MODV

DENVER--(BUSINESS WIRE)--Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, announced that, on August 21, 2025, the Company was notified by the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that Nasdaq had determined to commence proceedings to delist the Company’s common stock as a result of the Company’s

Modivcare Enters into Comprehensive Restructuring Agreement to Strengthen its Future, Reduce Debt and Inject Capital

MODV

DENVER--(BUSINESS WIRE)--Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced that it has taken necessary and decisive action intended to strengthen its financial foundation while continuing to provide access to care, reduce costs, and improve outcomes for clients and members nationwide. Modivcare has filed for voluntary Cha

Barrington Research Downgrades ModivCare to Market Perform

MODV

May 12, 2025
Read more →

ModivCare Q1 Adj. EPS $(1.71) Misses $(0.50) Estimate, Sales $650.65M Beat $645.87M Estimate

MODV

May 8, 2025
Read more →

Modivcare CFO And Chief Information Officer To Depart Following Transition Period; Co. Will Not Be Replacing These Roles At This Time

MODV

May 5, 2025
Read more →

Stephens & Co. Maintains Equal-Weight on ModivCare, Lowers Price Target to $3.5

MODV

March 10, 2025
Read more →

Barrington Research Maintains Outperform on ModivCare, Lowers Price Target to $6

MODV

March 7, 2025
Read more →

ModivCare Q4 Adj $0.19 Beats $0.18 Estimate, Sales $702.80M Miss $703.30M Estimate

MODV

March 6, 2025
Read more →

Barrington Research Maintains Outperform on ModivCare, Lowers Price Target to $10

MODV

January 14, 2025
Read more →

Lake Street Maintains Buy on ModivCare, Lowers Price Target to $10

MODV

January 13, 2025
Read more →

Modivcare Has Secured $75M In Incremental Financing, Backed By Stakeholders Across The Capital Structure, And Appointed Chad Shandler As Its Chief Transformation Officer. Existing Investor, Coliseum Capital Management, Has Also Committed $30M To Purchase

MODV

January 10, 2025
Read more →

Barrington Research Maintains Outperform on ModivCare, Maintains $25 Price Target

MODV

November 18, 2024
Read more →

ModivCare Affirms FY2024 Sales Guidance to $2.70B-2.90B VS Est.2.82B

MODV

November 6, 2024
Read more →

ModivCare Q3 Adj $0.45 Misses $0.77 Estimate, Sales $702.04M Miss $714.92M Estimate

MODV

November 6, 2024
Read more →